Consortium for Cancer Implementation Science Annual Meeting (Abstract)

Submitted by chancim on

Abstract Submission

We invite abstract submissions focused on the meeting theme: Advancing Implementation Science Across the Cancer Control Continuum. To submit an abstract for consideration as either a poster or oral presentation, use the form below.

Submissions will be reviewed based on the following abstract criteria:

  • Demonstrates rigor and relevance to implementation science in cancer control.
  • Aligns with at least one CCIS action group theme or objective.
  • Sufficiently addresses the meeting theme.
  • Illustrates the impact of science through intervention, methods, models, and study design. 

CCIS encourages early-stage investigators, graduate students and post-doctoral fellows, and practice partners to submit abstracts for consideration. Abstracts may describe research in progress and project completion is not required at the time of the conference.

Please note that all materials may undergo a review and approval process to ensure they are accurate, consistent, and aligned with NCI’s mission, goals, and current priorities. Submissions that do not reflect these standards may require revision.

The submission deadline is Monday, August 25, at 11:59 pm EST.

It is not possible to save partially completed abstracts. Therefore, we recommend preparing and finalizing the abstract and related information in a Word document, then cut and paste text into the appropriate fields. You will receive confirmation following your submission. If you do not receive the confirmation email (check your spam box also), please contact CCIS@icf.com.

Notification of acceptance will be in mid-October 2025. If an abstract is accepted, the corresponding author (or designated co-author) must register and attend the meeting in person; otherwise, the abstract will be withdrawn.

 

Collection of this information is authorized by The Public Health Service Act, Section 411 (42 USC 285a). Rights of participants are protected by The Privacy Act of 1974. All questions are optional and you may exit the survey at any time. Participation is voluntary and there are no penalties for not participating or withdrawing at any time. The information collected will be kept private to the extent provided by law. Names and other identifiers will not appear in any report. Information provided will be combined for all participants and reported as summaries. You are being contacted by email to complete this form so that the CCIS Planning Committee can determine presenters for the CCIS Annual Meeting.

Public reporting burden for this collection of information is estimated to average 10 minutes per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to: NIH, Project Clearance Branch, 6705 Rockledge Drive, MSC 7974, Bethesda, MD 20892-7974, ATTN: PRA (0925-0740). Do not return the completed form to this address.

OMB No.: 0925-0740
Expiration Date: 9/30/2025

Presenter Information

Please enter information for the person who will be the primary presenter/speaker/author.

Please use the following formatting for these degrees: MD, PhD, MPH
Indicate if the presenting author is currently in training (graduate student or post-doctoral fellow)
Indicate if the data for the abstract was supported by an NCI-funded grant
Abstract Information
  • Format: Only capitalize the first word of the title, proper nouns, and the first word after a colon used in a two-part title
  • Example: Implementation of the EPIC Wheel to promote social needs screening among cancer patients
Select preferred presentation format:
Select the most relevant keywords from list provided: (select all that apply)
Select the stage within the cancer control continuum that applies to your abstract: (select all that apply)
What is the scope of your work?
Format: Max 2300 characters (including spaces); text only
Must include these sections:
PURPOSE: (1-2 sentences, if possible)
METHODS:
RESULTS: (adequate to support conclusion)
CONCLUSIONS: (Do not use phrases such as "The results will be discussed")
Please use the following formatting for these degrees: M.D. Ph.D. MPH. Please do not list more than 10 authors.
First Name Middle Initial Last Name Degree(s) Author Affiliation Weight
more items